Results 161 to 170 of about 99,547,245 (298)
Population pharmacokinetics for the CTLA-4 modulator gotistobart in patients with advanced solid tumors. [PDF]
Li T +12 more
europepmc +1 more source
Extracellular vesicles (EVs) are a diverse population of membrane nanoparticles secreted by nearly all cell types, playing a key role in intercellular communication by transferring bioactive macromolecular cargo. In cancer, EVs shape both the local tumour microenvironment and distant premetastatic niches.
Evangelia Pantazaka +3 more
wiley +1 more source
Lung cancer brain metastasis is shaped by dynamic crosstalk among tumor cells, the blood–brain barrier, glial and immune cells, neurons, and metabolic niches. This review integrates these mechanisms with therapeutic resistance, translational models, CNS delivery, and multidisciplinary treatment strategies.
Jun Yang +6 more
wiley +1 more source
The effect of a PD-1/CTLA-4 tandem scFv on T cell cytokine response under immunosuppressive conditions. [PDF]
Maleki F +4 more
europepmc +1 more source
SLAMF6 recruits SHP‐2 to activate STAT1, upregulates CXCL10 and PD‐L1, promotes CD8+T cell infiltration, and enhances the efficacy of anti‐PD‐L1 therapy. ABSTRACT As a T‐cell receptor co‐stimulatory protein, signaling lymphocyte activation molecule family 6 (SLAMF6) is a member of the immune cell activating receptor family and is expressed on T cells ...
Yu Wu +8 more
wiley +1 more source
Encapsulated cell therapy for local anti-CTLA-4 delivery in cancer immunotherapy. [PDF]
Engel A +12 more
europepmc +1 more source
Immune surveillance of residual leukemic stem cells after tyrosine kinase inhibitor discontinuation involves coordinated NK‐cell, CTL, Treg, pDC, and neutrophil activity that predicts treatment‐free remission, while exhausted CTLs and Treg expansion predict relapse in chronic myeloid leukemia.
Hiroshi Ureshino, Shinya Kimura
wiley +1 more source
Soluble CTLA-4 as a context-dependent immune checkpoint: biology, biomarker potential, and therapeutic implications. [PDF]
Cai X +5 more
europepmc +1 more source

